title: Multi-targeted tyrosine kinase inhibitor sunitinib: a novel strategy for sporadic malignant pheochromocytoma.
abstract: Sporadic malignant pheochromocytoma, a rare disease with poor prognosis, is always difficult to treat due in part to lack of effective agents. We presented three patients with advanced malignant pheochromocytoma treated by sunitinib, which indicates that sunitinib is an effective agent for this malignancy.
authors.affiliation: Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
authors.forename: Fu-Kang
authors.initials: FK
authors.lastname: Sun
authors.forename: Hong-Chao
authors.initials: HC
authors.lastname: He
authors.forename: Ting-Wei
authors.initials: TW
authors.lastname: Su
authors.forename: Wen-Long
authors.initials: WL
authors.lastname: Zhou
authors.forename: Xin
authors.initials: X
authors.lastname: Huang
authors.forename: Jun
authors.initials: J
authors.lastname: Dai
authors.forename: Zhou-Jun
authors.initials: ZJ
authors.lastname: Shen
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000328:Adult; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010673:Pheochromocytoma / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D000077210:Sunitinib
chemical_list: D007211:Indoles; D047428:Protein Kinase Inhibitors; D011758:Pyrroles; D000077210:Sunitinib